What is the recommended treatment for a patient with acute sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acute Sinusitis Treatment

First-Line Antibiotic Therapy

Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days is the preferred first-line treatment for confirmed acute bacterial sinusitis in adults, providing superior coverage against β-lactamase-producing organisms. 1

When to Start Antibiotics

Antibiotics should only be prescribed when bacterial infection is confirmed by one of three clinical patterns: 1

  • Persistent symptoms ≥10 days without improvement 1
  • Severe symptoms (fever ≥39°C with purulent nasal discharge) for ≥3 consecutive days 1
  • "Double sickening" - worsening after initial improvement from a viral upper respiratory infection 1, 2

Critical context: 98-99.5% of acute sinusitis is viral and resolves spontaneously within 7-10 days without antibiotics. 1

Standard Dosing Regimens

For uncomplicated cases: 1, 3

  • Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days 1
  • Alternative: Amoxicillin 500 mg twice daily (mild disease) or 875 mg twice daily (moderate disease) 3

For high-risk patients (recent antibiotic use, age >65, moderate-to-severe symptoms, comorbidities): 1

  • High-dose amoxicillin-clavulanate 2 g/125 mg twice daily 1

Treatment Duration

Treat for 5-10 days, or until symptom-free for 7 days (typically 10-14 days total). 1, 3 Shorter 5-7 day courses have comparable efficacy with fewer adverse effects. 1

Penicillin-Allergic Patients

Non-Anaphylactic Allergy

For non-Type I penicillin allergy (rash, mild reactions), use second- or third-generation cephalosporins - the risk of cross-reactivity is negligible. 1

Recommended options: 1, 3

  • Cefuroxime-axetil (second-generation) 1
  • Cefpodoxime-proxetil (third-generation) 1
  • Cefdinir (third-generation) 1

All dosed for 10 days. 3

Severe Penicillin Allergy (Anaphylaxis)

For documented severe penicillin allergy, use respiratory fluoroquinolones as first-line therapy. 1, 4

  • Levofloxacin 500-750 mg once daily for 10-14 days 1, 4
  • Moxifloxacin 400 mg once daily for 10-14 days 1, 4

Critical pitfall: Never use azithromycin or other macrolides due to resistance rates exceeding 20-25% for both S. pneumoniae and H. influenzae. 1, 4

Second-Line Treatment for Failure

If no improvement after 3-5 days of initial therapy, switch to a respiratory fluoroquinolone. 1, 3

  • Levofloxacin 500-750 mg once daily for 10-14 days 1
  • Moxifloxacin 400 mg once daily for 10-14 days 1

These achieve 90-92% clinical efficacy against drug-resistant S. pneumoniae and β-lactamase-producing organisms. 1, 4

Alternative second-line option: 1

  • High-dose amoxicillin-clavulanate 2 g/125 mg twice daily 1

Essential Adjunctive Therapies

Prescribe intranasal corticosteroids for all patients with acute bacterial sinusitis to reduce mucosal inflammation and improve drainage. 1, 5

  • Mometasone, fluticasone, or budesonide twice daily 1
  • Number needed to treat: 14 4
  • Provides clinically important benefits with minimal systemic absorption 5

Additional supportive measures: 1, 6

  • Saline nasal irrigation for mucus clearance 1, 6
  • Analgesics (acetaminophen or NSAIDs) for pain 1, 6
  • Short-term oral corticosteroids (5 days) for marked mucosal edema or treatment failure 1, 3

Critical Monitoring Timepoints

Reassess at 3-5 days: If no improvement, switch antibiotics or re-evaluate diagnosis. 1, 3

Reassess at 7 days: Confirm diagnosis if symptoms persist or worsen. 1, 3

When to Refer to Specialist

Refer to otolaryngology or infectious disease if: 1, 4

  • No improvement after 7 days of appropriate second-line therapy 1
  • Worsening symptoms at any time 1
  • Suspected complications (orbital cellulitis, meningitis, abscess) 1, 4
  • Recurrent sinusitis (≥3 episodes per year) 1

Pediatric Considerations

For children, use amoxicillin 45 mg/kg/day in 2 divided doses for standard therapy. 1

For high-risk children (age <2 years, daycare, recent antibiotics): 1

  • High-dose amoxicillin 80-90 mg/kg/day in 2 divided doses 1

If no improvement at 72 hours, switch to high-dose amoxicillin-clavulanate (80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses). 1

Antibiotics to Avoid

Never use as first-line therapy: 1, 4

  • First-generation cephalosporins (cephalexin) - inadequate H. influenzae coverage 4
  • Azithromycin/macrolides - 20-25% resistance rates 1, 4, 7
  • Trimethoprim-sulfamethoxazole - 50% resistance for S. pneumoniae 4
  • Clindamycin monotherapy - no activity against H. influenzae or M. catarrhalis 4

Watchful Waiting Option

For uncomplicated acute bacterial sinusitis, watchful waiting without immediate antibiotics is appropriate when reliable follow-up can be assured. 1 Start antibiotics only if no improvement by 7 days or worsening at any time. 1

References

Guideline

Acute Sinusitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Sinusitis in Tracheostomy-Dependent Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Acute rhinosinusitis in adults.

American family physician, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.